Neon Therapeutics’ Personal Neoantigen Vaccine study (NT-001) demonstrated prolonged progression-free survival in advanced or metastatic melanoma, non-small cell lung cancer bladder cancers. The investigational drug, NEO-PV-01, in combination with OPDIVO (nivolumab),...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
